Takashi Suzuki (Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan)
Session information
Luncheon Seminar
LS1-13
The potential of HEMLIBRA® for hemophilia A patients with inhibitors.
Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.13 (Osaka International Convention Center, 11F 1101-2)
Chair: Satoshi Higasa (Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan)
Sponsor: Chugai Pharmaceutical Co., Ltd.